CORD BLOOD STEM CELLS

Currently, we use this type of stem cells to a limited extent for the treatment of diabetes mellitus in children and adolescents.

Type 1 diabetic patients treated with cord blood SC rarely return hyperglycemia in NOD mice, but they show profound immunomodulatory properties in humans. www.ncbi.nlm.nih.gov/pmc/articles/PMC3591677

Umbilical plasma injections reduce a person’s biological age.

www.pubmed.ncbi.nlm.nih.gov/36052758/